MYDA Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Hold
0
80
2022
Q3
Hold
0
149
2022
Q2
Hold
0
185
2020
Q1
Sell
-14,000
Closed -$853K 94
2019
Q4
$853K Buy
+14,000
New +$853K 0.37% 46